Financial Results

FY2019 Full Year Results (released on May 13, 2020)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor’s report)
Click to download


Press Release

Data Book
Click to download


For Investors & Analysts
 Earnings Release Presentation
 Committed to Bringing Better Health and a Brighter Future to People Worldwide
 
 Click to download

 Christophe Weber, President & Chief Executive Officer
 Andrew Plump, President, Research & Development
 Costa Saroukos, Chief Financial Officer, and others

 Audio Conference Call 6:00pm-7:15pm (Call 1: Presentation and Q&A Session)
 Audio Conference Call 9:30pm-10:30pm (Call 2: Q&A Session only)

For Media
 Earnings Release Presentation 
 Click to download

 Audio Conference Call 4:45pm-5:30pm (Presentation and Q&A Session)

Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download

FY2019 Q3 Results (released on February 4, 2020)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditor's Report)
Click to download


Press Release


Data Book
Click to download


Earnings Release Presentation
CONSOLIDATED FINANCIAL RESULTS FOR FY2019 Q3
Costa Saroukos, Chief Financial Officer
Click to download


Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download

Q3 Results Conference Call (presentation & Q&A) 6:00pm-7:00pm JST 
 
Alternative Timezone Conference Call (Q&A only) 10:00pm-11:00pm JST

FY2019 Q2 Results (released on October 31, 2019)

Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)
(Without Independent Auditors report)
Click to download

Press Release

Data Book
Click to download

Supplementary materials for Data Book
Click to download

Earnings Release Presentation

For Investors and Analysts

A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer
Andrew Plump, President, Research & Development
Costa Saroukos, Chief Financial Officer, and others
Click to download

For Media

A Competitive, Values-based, R&D-driven, Global Biopharmaceutical Leader
Christophe Weber, President & Chief Executive Officer, and others
Click to download


Supplementary materials for the financial statements
Underlying Core Reconciliation
Click to download

Financial FAQs regarding FY2019 Q2 earnings
Click to download

On-demand Webcast (Earnings meeting: For Investors & Analysts: 5:45pm-7:00pm JST)

On-demand Audio (Conference call 9:00pm-9:45pm JST)

FY2019 Q1 Results (released on July 31, 2019)

Partial Correction of Financial Statements submitted to TSE (Tokyo Stock Exchange)
Click to download


Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)

(Without Independent Auditor’s report)
Click to download


Press Release
 

Data Book
Click to download


Earnings Release Presentation

CONSOLIDATED FINANCIAL RESULTS FOR FY2019 Q1
Costa Saroukos, Chief Financial Officer
Click to download


Supplementary materials for the financial statements

Underlying Core Reconciliation
Click to download

Financial FAQs regarding FY2019 Q1 earnings
Click to download


Audio Conference Call

Financial Results Archive